Maurice Pharmaceuticals (Opc) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth 46.24%
- Ebitda 51.58%
- Net Worth -19.37%
- Total Assets 0.25%
About Maurice Pharmaceuticals (Opc)
Maurice Pharmaceuticals (Opc) Private Limited (MPOPL) is a Company incorporated in India on 18 August 2017 (Seven years and five months 11 days old ). Its registered office is in Kamrup, Assam, India.
The Corporate was formerly known as Dewlife Pharmaceuticals (Opc) Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Foridul Hussain serves as a director at the Company.
Company Details
- Location
Kamrup, Assam, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24290AS2017OPC018102
- Company No.
018102
- Incorporation Date
18 Aug 2017
- Date of AGM
-
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Who are the key members and board of directors at Maurice Pharmaceuticals (Opc)?
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Foridul Hussain  | Director | 18-Aug-2017 | Current |
Financial Performance of Maurice Pharmaceuticals (Opc).
Maurice Pharmaceuticals (Opc) Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 46.24% increase in profit. The company's net worth observed a substantial decline by a decrease of 19.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maurice Pharmaceuticals (Opc)?
Unlock access to Maurice Pharmaceuticals (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Dew Care Hospital LlpForidul Hussain is a mutual person
- Amber Health & Nutrition Private Limited
Foridul Hussain is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Maurice Pharmaceuticals (Opc)?
Unlock and access historical data on people associated with Maurice Pharmaceuticals (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maurice Pharmaceuticals (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maurice Pharmaceuticals (Opc)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.